東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回上頁

切換: 標籤 | MARC模式 | ISBD

Protein tyrosine kinases : = from in...

Fabbro, D.

FindBook

Google Book

Amazon

博客來

Protein tyrosine kinases : = from inhibitors to useful drugs /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Protein tyrosine kinases :/ edited by Doriano Fabbro and Frank McCormick.
其他題名:	from inhibitors to useful drugs /
其他作者:	Fabbro, D.
出版者:	Totowa, N.J. :Humana Press, : c2006.,
面頁冊數:	xiii, 290 p. :ill. (some col.) ;24 cm.
叢書名:	Cancer drug discovery and development.
內容註:	Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery/ Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations/ Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma/ Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists/ Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer/ Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.
標題:	Cancer - Chemotherapy. -
電子資源:	http://www.loc.gov/catdir/toc/ecip059/2005006248.htmlhttp://www.loc.gov/catdir/toc/ecip059/2005006248.html
ISBN:	158829384X :

Protein tyrosine kinases : = from inhibitors to useful drugs /
Protein tyrosine kinases :from inhibitors to useful drugs /edited by Doriano Fabbro and Frank McCormick. - Totowa, N.J. :Humana Press,c2006. - xiii, 290 p. :ill. (some col.) ;24 cm. - Cancer drug discovery and development..

Includes bibliographical references and index.

Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery/ Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations/ Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma/ Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists/ Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer/ Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.

ISBN: 158829384X :US175.00

LCCN: 2005006248Subjects--Topical Terms:

753516
Cancer
--Chemotherapy.

LC Class. No.: RC271.P76 / P76 2006

Dewey Class. No.: 616.99/4061

Protein tyrosine kinases : = from inhibitors to useful drugs /
LDR:01954pam a2200205 a 45 001 708312
005 20061214
008 061107s2006 nju b 001 0 eng
010 $a 2005006248
020 $a 158829384X : $c US175.00
035 $a BT95T0018
040 $a DLC $c DLC $d DLC
050 0 0 $a RC271.P76 $b P76 2006
082 0 0 $a 616.99/4061 $2 22
245 0 0 $a Protein tyrosine kinases : $b from inhibitors to useful drugs / $c edited by Doriano Fabbro and Frank McCormick.
260 $a Totowa, N.J. : $c c2006. $b Humana Press,
300 $a xiii, 290 p. : $b ill. (some col.) ; $c 24 cm.
440 0 $a Cancer drug discovery and development.
504 $a Includes bibliographical references and index.
505 0 $a Protein tyrosine kinases as targets for cancer and other indications / Mark Pearson, Carlos Garcia-Echeverria, Doriano Fabbro -- Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery/ Carlos Garcia-Echeverria -- PI 3-kinase inhibition: a target for therapeutic intervention / Peter M. Finan, Stephen G. Ward -- Src as a target for pharmaceutical intervention: potential and limitations/ Mira Susa ... [et al.] -- Activated FLT3 receptor tyrosine kinase as a therapeutic target in leukemia / Blanca Scheijen, James D. Griffin -- JAK kinases in leukemias/lymphomas and multiple myeloma/ Renate Burger, Martin Gramatzki -- Glivec (Gleevec, Imatinib, STI571): a targeted therapy for CML / Elisabeth Buchdunger, Renaud Capedeville -- Platelet-derived growth factor: normal function, role in disease, and applications of PDGF antagonists/ Tobias Sjoblom ... [et al.] -- Structural biology of protein tyrosine kinases / Sandra W. Cowan-Jacob ... [et al.] -- Testing of signal transduction inhibitors in animal models of cancer/ Terence O'Reilly, Robert Cozens -- Phosphoproteomics in drug discovery and development / Michel F. Moran.
650 $a Cancer $x Chemotherapy. $3 753516
650 $a Protein-tyrosine kinase $x Inhibitors $x Therapeutic use. $3 770827
700 $a Fabbro, D. $3 770825
700 $a McCormick, Frank, $d 1950-. $3 770826
856 4 1 $3 Table of contents $u http://www.loc.gov/catdir/toc/ecip059/2005006248.html $z http://www.loc.gov/catdir/toc/ecip059/2005006248.html